✦ LIBER ✦

Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

✍ Scribed by Pierre Amarenco; Larry B. Goldstein; Alfred Callahan III; Henrik Sillesen; Michael G. Hennerici; Blair J. O’Neill; Amy E. Rudolph; Lisa Simunovic; Justin A. Zivin; K.M.A. Welch

Book ID: 118422291
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 203 KB
Volume: 204
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2008.09.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose atorvastatin and risk of atria

High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

✍ Gregory G. Schwartz; Bernard R. Chaitman; Jeffrey J. Goldberger; Michael Messig 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Beyond Low-Density Lipoprotein Cholester

Beyond Low-Density Lipoprotein Cholesterol: Respective Contributions of Non–High-Density Lipoprotein Cholesterol Levels, Triglycerides, and the Total Cholesterol/High-Density Lipoprotein Cholesterol Ratio to Coronary Heart Disease Risk in Apparently Healthy Men and Women

✍ Benoit J. Arsenault; Jamal S. Rana; Erik S.G. Stroes; Jean-Pierre Després; Predi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 354 KB

The role of niacin in raising high-densi

The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH) trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Baseline Characteristics of Participants

Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

✍ Paul M. Ridker; Francisco A.H. Fonseca; Jacques Genest; Antonio M. Gotto; John J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 119 KB

On-Treatment Non–High-Density Lipoprotei

On-Treatment Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy: JUPITER (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)

✍ Samia Mora; Robert J. Glynn; S. Matthijs Boekholdt; Børge G. Nordestgaard; John 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Relationship of Oxidized Phospholipids a

Relationship of Oxidized Phospholipids and Biomarkers of Oxidized Low-Density Lipoprotein With Cardiovascular Risk Factors, Inflammatory Biomarkers, and Effect of Statin Therapy in Patients With Acute Coronary Syndromes: Results From the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) Trial

✍ Alexander E. Fraley; Gregory G. Schwartz; Anders G. Olsson; Scott Kinlay; Michae 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 561 KB